SEC Form 5 · accession 0000904454-16-000985
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 11:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 8, 2015 | S | 1,010,265 | $48.00 | D | 2,066,740 | I | By Johnson & Johnson Innovation - JJDC, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owed subsidiary of the Reporting Person.